PERRIGO Co plc
PRGO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585364
No open-market purchases or sales by PERRIGO Co plc insiders were filed in the last 90 days; 340 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Maverick Capital is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by PERRIGO Co plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for PERRIGO Co plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Parker Geoffrey M. | Director | 33,873 | Sep 15, 2026 | 6 |
| Alford Bradley A | Director | 46,121 | Sep 15, 2026 | 5 |
| Ball David | EVP & CBDO | 11,664 | Sep 10, 2026 | 4 |
| Manzone Albert | Interim President and CEO | 16,353 | Jul 23, 2026 | 3 |
| Amin Ahmed Salman | Director | – | Jul 15, 2026 | 1 |
| Gajial Muhammad Omer | Director | – | Jul 15, 2026 | 1 |
| Bezerra Eduardo Guarita | EVP & Chief Financial Officer | 84,700 | Jul 10, 2026 | 5 |
| Khoury Roberto | EVP and President of CSCI | 14,113 | Jul 10, 2026 | 4 |
| Atkinson Charles | EVP, General Counsel & Sec. | 5,855 | Jul 10, 2026 | 3 |
| Winterman Matthew John | EVP, Supply, Ops, Strategy | 8,365 | Jul 10, 2026 | 3 |
| Willis Robert | EVP & CHRO | 50,568 | Jul 10, 2026 | 5 |
| Lennox Abigail | EVP and CSO | 4,607 | Jul 10, 2026 | 4 |
| Lockwood-Taylor Patrick | Other: Former CEO and director | 123,170 | Jun 9, 2026 | 4 |
| Ashford Orlando D | Director | 27,717 | May 15, 2026 | 1 |
| O'Connor Donal | Director | 34,435 | May 15, 2026 | 1 |
| Brown Julia M | Director | 11,832 | May 15, 2026 | 1 |
| Samuelson Jonas | Director | 5,392 | May 15, 2026 | 2 |
| Egan Kevin Francis | Director | 3,798 | May 15, 2026 | 1 |
| Janish Ronald Craig | EVP, Gbl Ops & SC & CTO | 35,558 | Jun 10, 2025 | 0 |
| Schmelter Triona | EVP & President CSCA | 6,670 | Jun 10, 2025 | 0 |
| Kindler Jeffrey B | Director | 10,559 | May 16, 2025 | 0 |
| Karaboutis Adriana | Director | 27,629 | May 16, 2025 | 0 |
| Doyle Katherine C. | Director | 6,009 | Sep 13, 2024 | 0 |
| Andersen Svend | EVP & President CHCI | 7,000Indirect | Aug 21, 2024 | 0 |
| Ives Alison | EVP & Chief Scientific Officer | 18,451 | Jul 10, 2024 | 0 |
| Kingma Todd W | Executive VP, General Counsel | 45,269 | Jun 11, 2024 | 0 |
| Mann Erica L | Director | 17,458 | May 16, 2024 | 0 |
| Hanson Kyle | EVP & General Counsel | 11,137 | Apr 9, 2024 | 0 |
| Farrington Thomas | EVP and CIO | 10,693 | Apr 9, 2024 | 0 |
| Quinn Grainne | EVP, Chief Medical Officer | 21,078 | Apr 9, 2024 | 0 |
| Kessler Murray S | CEO | 2,668 | May 15, 2023 | 0 |
| Dillard James E III | EVP & President CSCA | 25,130 | Mar 14, 2023 | 0 |
| Samuels Theodore R. II | Director | 26,693 | May 19, 2022 | 0 |
| Silcock Raymond | EVP, Chief Financial Officer | 59,488 | Apr 7, 2022 | 0 |
| Classon Rolf A | Director | 17,442 | Dec 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Classon Rolf ADirector | PPurchase | +2.80K | $35.67 | +$99.9K | +19.1%17.4K after | |
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Silcock RaymondEVP, Chief Financial Officer | PPurchase | +27.5K | $36.03 | +$990.8K | +269.7%37.7K after | |
| Dec 7, 2021 (view filing) | Dec 6 | 1 day | Andersen SvendEVP & President CHCI | PPurchase | +3.65K | $37.10 | +$135.6K | +36.4%13.7K after | 2 lots |
| Dec 16, 2021 (view filing) | Dec 16 | Same day | Alford Bradley ADirector | PPurchase | +13.0K | $36.88 | +$479.4K | +118.4%24.0K after | |
| Dec 17, 2021 (view filing) | Dec 16 | 1 day | Parker Geoffrey M.Director | PPurchase | +5.00K | $36.85 | +$184.3K | +85.0%10.9K after | |
| Dec 20, 2021 (view filing) | Dec 17 | 3 days | Kingma Todd WExecutive VP, General Counsel | PPurchase | +3.00K | $37.55 | +$112.7K | +6.1%51.9K after | |
| Mar 8, 2022 (view filing) | Mar 7 | 1 day | Janish Ronald CraigEVP, Gbl Ops & SC & CTO | SSale | −3.95K | $36.73 | −$145.2K | −20.1%15.7K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Farrington ThomasEVP and CIO | SSale | −24.5K | $37.13 | −$909.1K | −100.0%0 after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Farrington ThomasEVP and CIO | SSale | −2.26K | $37.23 | −$84.1K | −100.0%0 after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Quinn GrainneEVP, Chief Medical Officer | SSale | −2.37K | $31.65 | −$74.9K | −20.6%9.12K after | |
| Mar 7, 2023 (view filing) | Mar 6 | 1 day | Parker Geoffrey M.Director | PPurchase | +5.00K | $38.05 | +$190.3K | +46.0%15.9K after | |
| Mar 9, 2023 (view filing) | Mar 8 | 1 day | Janish Ronald CraigEVP, Gbl Ops & SC & CTO | SSale | −4.50K | $36.92 | −$166.1K | −18.2%20.2K after | |
| Mar 14, 2023 (view filing) | Mar 13 | 1 day | Farrington ThomasEVP and CIO | SSale | −3.72K | $35.57 | −$132.4K | −56.9%2.82K after | 2 lots |
| Mar 14, 2023 (view filing) | Mar 10 | 4 days | Dillard James E IIIEVP & President CSCA | SSale | −9.00K | $35.70 | −$321.3K | −26.4%25.1K after | |
| May 15, 2023 (view filing) | May 11 | 4 days | Kessler Murray SCEO | SSale | −197.6K | $35.75 | −$7.07M | −98.7%2.67K after | |
| May 25, 2023 (view filing) | May 23 | 2 days | Andersen SvendEVP & President CHCI | PPurchase | +2.90K | $33.41 | +$96.9K | +4.4%68.7K after | |
| Jun 14, 2023 (view filing) | Jun 13 | 1 day | Parker Geoffrey M.Director | PPurchase | +10.0K | $33.06 | +$330.6K | +63.0%25.9K after | |
| Nov 14, 2023 (view filing) | Nov 14 | Same day | Lockwood-Taylor PatrickCEO | PPurchase | +11.0K | $28.99 | +$318.9K | New position11.0K after | |
| Nov 15, 2023 (view filing) | Nov 14 | 1 day | Bezerra Eduardo GuaritaEVP & Chief Financial Officer | PPurchase | +5.00K | $29.18 | +$145.9K | +145.9%8.43K after | |
| Nov 27, 2023 (view filing) | Nov 24 | 3 days | Willis RobertEVP & CHRO | PPurchase | +5.55K | $31.01 | +$172.1K | +40.9%19.1K after | |
| Feb 29, 2024 (view filing) | Feb 29 | Same day | Lockwood-Taylor PatrickCEO | PPurchase | +9.50K | $26.54 | +$252.1K | +86.4%20.5K after | |
| Mar 1, 2024 (view filing) | Feb 29-Mar 1 | 1 day | Willis RobertEVP & CHRO | PPurchase | +6.37K | $25.90 | +$165.0K | +33.3%25.5K after | 2 lots |
| Mar 7, 2024 (view filing) | Nov 16, 2023 | 112 days | Ives AlisonEVP & Chief Scientific Officer | PPurchase | +2.04K | $29.34 | +$59.9K | +23.0%10.9K after | Amended |
| Mar 7, 2024 (view filing) | Feb 29 | 7 daysLate | Ives AlisonEVP & Chief Scientific Officer | PPurchase | +1.54K | $26.44 | +$40.8K | +14.2%12.4K after | |
| Mar 7, 2024 (view filing) | Mar 5 | 2 days | Ives AlisonEVP & Chief Scientific Officer | PPurchase | +2.49K | $27.26 | +$67.9K | +18.3%16.1K after | |
| May 31, 2024 (view filing) | May 28 | 3 daysLate | Andersen SvendEVP & President CHCI | PPurchase | +1.00K | $27.90 | +$27.9K | +1.0%101.9K after | |
| Aug 21, 2024 (view filing) | Aug 20 | 1 day | Andersen SvendEVP & President CHCI | SSale | −28.3K | $27.75 | −$785.3K | −27.8%73.6K after | 2 lots |
| Aug 21, 2024 (view filing) | Aug 20 | 1 day | Andersen SvendEVP & President CHCI | SSale | −6.68K | $27.43 | −$183.3K | −48.8%7.00K after | |
| Aug 28, 2024 (view filing) | Aug 26 | 2 days | Janish Ronald CraigEVP, Gbl Ops & SC & CTO | SSale | −13.0K | $29.40 | −$382.2K | −38.7%20.6K after | |
| Sep 13, 2024 (view filing) | Sep 13 | Same day | Doyle Katherine C.Director | SSale | −8.95K | $27.30 | −$244.4K | −59.8%6.01K after | |
| Dec 10, 2024 (view filing) | Dec 9 | 1 day | Kindler Jeffrey BDirector | SSale | −17.6K | $28.27 | −$497.5K | −76.5%5.41K after | 10b5-1 |
| Mar 10, 2025 (view filing) | Mar 10 | Same day | Janish Ronald CraigEVP, Gbl Ops & SC & CTO | SSale | −7.80K | $27.44 | −$214.0K | −18.8%33.7K after | |
| May 14, 2025 (view filing) | May 12 | 2 days | Parker Geoffrey M.Director | PPurchase | +3.50K | $27.10 | +$94.8K | +17.3%23.8K after | |
| Aug 8, 2025 (view filing) | Aug 8 | Same day | Lockwood-Taylor PatrickCEO | PPurchase | +4.46K | $22.37 | +$99.8K | +5.5%85.8K after | 3 lots |
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Bezerra Eduardo GuaritaEVP & Chief Financial Officer | PPurchase | +3.00K | $22.74 | +$68.2K | +6.5%48.9K after | |
| Aug 20, 2025 (view filing) | Aug 18 | 2 days | Parker Geoffrey M.Director | PPurchase | +4.38K | $22.97 | +$100.5K | +79.5%9.88K after | Amended |
| Aug 22, 2025 (view filing) | Aug 22 | Same day | Willis RobertEVP & CHRO | PPurchase | +1.49K | $24.10 | +$35.9K | +3.7%41.9K after | |
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | Atkinson CharlesEVP, General Counsel & Sec. | PPurchase | +1.00K | $23.20 | +$23.2K | New position1.00K after | |
| Sep 10, 2025 (view filing) | Sep 8 | 2 days | Lennox AbigailEVP and CSO | PPurchase | +1.25K | $22.41 | +$28.1K | New position1.25K after | |
| Nov 14, 2025 (view filing) | Nov 12 | 2 days | Parker Geoffrey M.Director | PPurchase | +7.50K | $14.18 | +$106.3K | +75.9%17.4K after |